Main description:

The main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments.
Besides standard methods such as surgery, chemotherapy, radiotherapy, and hormone therapy, newly developed biological treatments, targeted treatments, personalized treatments, external beam radiotherapy, and targeted radionuclide treatments have begun to take their place in professional practice.

Nuclear medicine, in addition to its role as a tracer of cancer, also assumes the role of treating with radioactive molecules directed to the cancer it traces. These traceable next-generation radionuclide treatments, whose efficacy and reliability have been proven and where diagnosis, treatment, and follow-up are carried out together, are increasingly included in oncology practice together with the new developed radiopharmaceuticals, ensuring a high rate of damage to cancer cells while protecting the surrounding normal tissues. Molecular cancer treatment will become more effective with individualized next-generation traceable radionuclide treatments, which will be shaped by genetic studies in the future.

Radionuclide treatments for many cancer types and benign diseases are presented by experienced nuclear medicine experts in the light of their own experience and case studies, while systemic treatments in common cancer types and side effect management of these treatments are summarized by medical oncologists.

This book will be of interest to nuclear medicine physicians as well as oncologists.

Contents:

Part-1: Basic Information 1. Basic properties and preparation of radiopharmaceuticals used in radionuclide therapy2. Physical Bases of Radionuclide Therapy (Biological Effects and Properties of Particle Radiation)3. Fundamentals of radiation safety and dosimetric approach in radionuclide therapy applicationsPart-2: Clinical Information: Thyroid Diseases
4. Radionuclide Therapy in Benign Thyroid Diseases: Nodular Goiter Disease5. Radionuclide Therapy in Benign Thyroid Diseases: Graves' Disease 6. Radionuclide Therapy in Malignant Thyroid Diseases: Differentiated Thyroid Cancer7. Radionuclide Therapy in Malignant Thyroid Diseases: Medullary Thyroid Cancer 8. Systemic Treatments and related side effects in Thyroid Cancer Part-2: Clinical Information: Neuroendocrine Tumors
9. Radionuclide Therapy in Neuroendocrine Tumors10. Systemic Treatments and related side effects in Neuroendocrine Tumors Part-4: Clinical Information: Neuroectodermal Tumors
11. Radionuclide Therapy in Neuroectodermal Tumors12. Systemic Treatments and related side effects in Neuroectodermal Tumors Part-5: Clinical Information: Liver Tumors
13. Radionuclide Therapy in Liver Tumors14. Systemic Treatments and related side effects in Liver TumorsPart-6: Clinical Information: Prostate Cancer
15. Radionuclide Therapy in Prostate Cancer16. Systemic Treatments and related side effects in Prostate Cancer17. Radionuclide Therapy in Joint Diseases: Radiosynovectomy18. Radionuclide Pain Palliation TherapyPart-7: Clinical Information: Bone and Joint Diseases
19. Radionuclide Therapy with Alpha Emitting Agents in Bone Metastases Part-8: Clinical Information: Lymphoproliferative Diseases
20. Radionuclide Therapy in Lymphoproliferative Diseases
Part-9: Radioimmunotherapy
21. Basics and clinical applications of radioimmunotherapy
Part-10: Intracavitary Radionuclide Therapy
22. Intracavitary radionuclide applications